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Exploration Laboratory Analysis (ELA) –
FY15 Project Overview
• Background
– ExMC Risk and Gap
– ELA Objective
• ELA Downselect
– Criteria
– Technology Selections
• Summary & FY16 Plans
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Exploration Medical Capability (ExMC)
Risk and Gap
Risk –
Risk of Adverse Health Outcomes & Decrements in Performance 
due to Inflight Medical Conditions 
Med 13:
We do not have the capability to implement medical resources 
that enhance operational innovation for medical needs.
Research Approach for ELA:
Develop the capability to measure clinically significant laboratory 
analytes in a minimally invasive manner during exploration missions.
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ELA Objective
Demonstrate the feasibility of emerging ELA 
operational and analytical capability as a 
biomedical diagnostics precursor to long 
duration manned exploration missions.
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TECHNOLOGY DOWNSELECT
Exploration Laboratory Analysis
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ELA Operational Measurements
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Technology Status
7
Point-of-Care (POC) Devices
• For more than a decade, POC devices have emerged for:
– Bedside care; doctor’s office.
– Care in remote locations (e.g. 3rd World, developing nations).
– Military operations in forward combat locations.
• POC technologies are generally compact instruments.
– However, often limited in the breadth of measurements
– Typically offer a subset of the ExMC operational analyte
• Clinically validated, commercial-off-the-shelf (COTS) instruments are 
emerging that can provide all measurements.
– Mass, volume, power and space readiness do not align with exploration mission 
restrictions.
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ELA Technology Downselect Criteria
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Decision Factors Criteria Criteria Definition
Clinical Analysis
Validated Measurements Number of validated, operational measurements demonstrated by the analytical platform.
Assay Capability (Technology 
Limitations)
Technological capability to provide additional 
operational measurements beyond current menu.
Multiplexing Multiplexed measurements capable on the analytical platform.
Reagent/Cartridge Shelf-Life Demonstrated ambient storage
Engineering
Mass/Volume Instrument massInstrument volume
Fluidics Microfluidics transport and control
Reagent/Cartridge Waste Volume of disposables per run
Space Readiness (Hardware maturity) Device complexity; space readiness
Cost & Schedule
Instrument Cost Cost to acquire an instrument
Ability to Work with Manufacturer Responsiveness to NASA
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Downselect Technology #1
Cell Phone-Based Lateral Flow Assay for Blood Biomarker Detection
Intelligent Optical Systems (IOS) & Holomic LLC
IOS: LFA Development for 
Blood-Based Testing
Target Assay Panels: 
• Cardiac Biomarkers:
- Troponin I  (TnI)
• Liver Function Panel:
- Alanine Aminotransferase (ALT)
- Aspartate Aminotransferase (AST)
- Alkaline Phosphatase (ALP) 
• Blood Chemistry Panel
- Creatinine, Glucose, Na, K, BUN
• Dissolved Blood Gas Panel
- Dissolved Oxygen, CO2, pH
M. Krihak, PhD 2016 NASA Human Research Program Investigators’ Workshop 10
On Going Development:
• Design and deliver a fully automated reader for various 
fluorescent assays.
• Automated mechanical switching of band-pass filters 
will enhance automation for measuring multiple panels.
Holomic, LLC: Development of a Prototype Fluorescent Reader and 
Data Processing Software for On-cell Phone
Reader Dimensions
 Designed with limited space 
consideration.
 Reader weight (including phone) is 
10.8 oz.; reader volume is ~420 cm3
 At the cost of a smaller imaging field-
of-view, the height may be reduced to 
<5 cm by substituting an imaging lens 
with a shorter focal length.
Reader application 
screenshots of 
recently added 
features
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Downselect Technology #2
rHEALTH Technology – DNA Medicine Institute
Spiral Vortexer
Nanostrip
s
Optical Block
Vitals Patch C.H.A.S. Microgravity Small Sample
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rHEALTH X Capabilities
LYM
GRAN  3-part counts
 Differential antibody staining
Chan, E. et al. rHEALTH Sensor:  Universal In-Flight Biomedical Analysis Technology. in 2013 
NASA Human Research Program Investigators' Workshop (Galveston, Texas, 2013)
Optical block
405 nm, 532 nm lasers
3 single photon counters
WBC 3-Part Diff
Optical Block Performance
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Summary & FY16 Plans
• ELA Downselect technologies identified.
– Intelligent Optical Systems/Holomic, LLC
• Lateral flow strip assays read by smartphone analyzer.
– DNA Medicine Institute
• Handheld rHEALTH flow through analyzer.
• Delivered the ExMC Exploration Laboratory Analysis Downselect
Recommendation Report (ARC Document No. 6973).
• FY16 objectives
– Develop strategy that identifies roadmap to guide project completion.
– Identify ELA integration points with an exploration medical system.
